MetaCap

Anteris Technologies Global (AVR) vs Tactile Systems Technology (TCMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Tactile Systems Technology (TCMD) has outperformed Anteris Technologies Global (AVR) over the past year, gaining 48.5% versus a gain of 38.7%. Anteris Technologies Global is the larger company by market cap ($659.8 million vs $508.3 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AVR+38.70%TCMD+48.46%
+129%+46%-37%
Oct 8, 20251 yearOct 8, 2026
AVR+18.39%TCMD+23.47%
+90%+13%-63%
Dec 9, 20245 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AVR versus TCMD key metrics
MetricAVRTCMD
Share price$6.77$22.44
Market cap$659.79M$508.32M
1-day change+2.11%+1.45%
YTD return+32.87%-23.72%
1-year return+38.70%+48.46%
5-year return—-37.69%
P/E ratio (TTM)—20.78
Forward P/E—15.42
EPS (TTM)$-1.95$1.08
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$11.06$37.77
52-week low$3.30$14.00
Distance from 52-week high-38.76%-40.59%
Analyst consensusstrong_buynone
Avg. price target upside+106.79%+73.80%
Average volume935.07K298.31K
Shares outstanding97.46M22.65M
Employees1741,086
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Anteris Technologies Global

AVR stock →

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.

Health Care · Industrial Specialties · 174 employees

About Tactile Systems Technology

TCMD stock →

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.

Health Care · Medical/Dental Instruments · 1,086 employees

AVR vs TCMD FAQ

Which is bigger, Anteris Technologies Global or Tactile Systems Technology?

Anteris Technologies Global (AVR) is larger, with a market capitalization of $659.79M compared with $508.32M for Tactile Systems Technology (TCMD).

Which stock has performed better over the past year, AVR or TCMD?

TCMD returned +48.46% over the past 12 months, compared with +38.70% for AVR (price return, excluding dividends). Past performance does not predict future results.

Are Anteris Technologies Global and Tactile Systems Technology in the same industry?

Both are in the Health Care sector, but in different industries: Industrial Specialties for Anteris Technologies Global and Medical/Dental Instruments for Tactile Systems Technology.

More comparisons